/Companies

Vivodyne

Brisbane, US · Founded 2020 · Delaware corporation · 38 employees on LinkedIn · 8 known investors

Find your way into Vivodyne

Sign up to see every warm intro you have to Vivodyne

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Vivodyne team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Vivodyne is a bio-AI company that develops lab-grown human tissues and robotic systems to generate causal biological data for therapeutic development. The platform produces high-resolution phenomic, transcriptomic, and proteomic data from human tissue models to enable drug discovery and development.

Founders & leadership

Vivodyne was founded in 2020 by Dongeun Huh and Andrei Georgescu.

DH
Dongeun HuhCo-founder
AGAndrei Georgescu
Andrei GeorgescuCo-founder · Chief Executive Officer
DH
Dan HuhFounder

Board

QS
Quinten StevensBoard director
AA
Alex AndrianopolousBoard director
AMAlex Morgan
Alex MorganBoard directorInvestor at Khosla Ventures
AAALEX ANDRIANOPOULOS
ALEX ANDRIANOPOULOSInvestor, Board MemberChief R&D Officer at Kairos Venture Investments, Llc
JO
Julie O'ShaughnessyBoard director

Investors · 8

Reported raises · per SEC filings

Form D private placements

$79.7M disclosed across 2 rounds · 2021–2025

▶$77.7MraisedJun 2025 · 18 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Julie O'ShaughnessyDirector
  • Andrei GeorgescuExecutive Officer, Director
  • Quinten StevensDirector
  • Alex AndrianopolousDirector
  • Dongeun HuhExecutive Officer, Director
  • Alex MorganDirector
Offering amount
$77.7M
Amount sold
$77.7M
First sale
Feb 2025
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedMar 2021 · 1 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • ANDREI GEORGESCUExecutive Officer, Director
  • DONGEUN HUHExecutive Officer, Director
  • ALEX ANDRIANOPOULOSDirector
Offering amount
$4M
Amount sold
$2M
First sale
Mar 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 5

Companies working in the same space as Vivodyne.

In the news

Frequently asked questions

What does Vivodyne do?
Vivodyne is a bio-AI company that develops lab-grown human tissues and robotic systems to generate causal biological data for therapeutic development. The platform produces high-resolution phenomic, transcriptomic, and proteomic data from human tissue models to enable drug discovery and development.
Who founded Vivodyne?
Vivodyne was founded by Dongeun Huh, Andrei Georgescu in 2020.
Who are Vivodyne's investors?
Vivodyne's investors include Bison Ventures, Kairos Venture Investments, Llc, Khosla Ventures, Lingotto, Scribble Ventures, Exor Seeds, Fortius Ventures, MBX Capital.
How much funding has Vivodyne raised?
Vivodyne has disclosed $79.7M raised across 2 rounds.
Where is Vivodyne headquartered?
Vivodyne is headquartered in Brisbane, US.